Bristol-Myers Squibb Company
Related Organizations
Data about an organization is collected from a variety of government sources and there is no standardized name or common identifier across data sources. Digital Democracy experts make judgments about which entries are related, such as an organization that has various spellings or a corporation and its affiliates. Those relationships are used to determine financial contributions and advocacy on legislation. Below are the entities that Digital Democracy has linked to the organization above:
- Bristol-Myers Squibb
- Bristol-Meyers Squibb Company
- BRISTOL MYER SQUIBB
- BRISTOL MYERS SQUIBB
- BRISTOL-MEYER SQUIBB COMPANY
- ER SQUIBB & SONS, LLCSOPHIA PARK
- BRISTOL MYERS SQUIBB / ER SQUIBB & SONS, LLCSARAH SWAN
- ER SQUIBB & SONS LLC
- BRISTOL MYERS SQUIBBCORPORATION
- E R SQUIBB & SONS LLCJEFFREY GALIK
- ER SQUIBB & SONS LLCSARAH SWAN
- E R SQUIBB & SONS LLC
- E R SQUIBB & SONS, LLCREQUESTED
- BRISTOL MYERS SQUIBB / ER SQUIBB & SONS LLC
- BRISTOL MYERS SQUIBB / ER SQUIBB & SONS LLCSARAH SWAN
- BRISTOL MYERS SQUIBB COMPANY ITS SUBSIDIARY ER SQUIBB & SONS LLC
- BRISTOL MYERS SQUIBB / ER SQUIBB & SONS, LLCDAVID ELKINS
Bill Alignment
Bill Alignments represents this person's position on legislation and, where it applies, the organization they were representing. These positions are captured from in-person testimony and written positions that have been submitted to committees. The data covers 2015-18 and 2023-present.
Year:
Bill | Representing | Last Recorded Position | |
|---|---|---|---|
| AB 463: Pharmaceutical Cost Transparency Act of 2016. | Self | Against | |
| SB 671: Pharmacy: biological product. | Self | Support |
Financials
Below is a list of financial exchanges between this organization and current legislators including campaign donations, gifts, independent expenditures or travel expenses. The data covers 2015-present.
Financials Loading...
